Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Nuvalent Completes $135 Million Series B Financing To Advance Portfolio Of Novel Precisely Targeted Kinase Inhibitors For Treatment-Resistant Cancers
Nuvalent Completes $135 Million Series B Financing To Advance Portfolio Of Novel Precisely Targeted Kinase Inhibitors For Treatment-Resistant Cancers
Company Info
Company news
Tue, 26 Nov 2024 08:00:00 GMT
Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference - PR Newswire
Fri, 13 Sep 2024 07:00:00 GMT
Nuvalent Announces Publication in Cancer Discovery Detailing Design and Characterization of ALK-selective inhibitor NVL-655 - PR Newswire
Sat, 07 Dec 2024 08:00:00 GMT
Nuvalent: Steps Toward That Favorable Entry Point - Seeking Alpha
Thu, 08 Aug 2024 07:00:00 GMT
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2024 Financial Results - PR Newswire
Mon, 16 Sep 2024 07:00:00 GMT
Nuvalent Announces Pricing of Upsized Public Offering of Common Stock - PR Newswire
Thu, 16 May 2024 07:00:00 GMT
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 - PR Newswire
Thu, 11 Jul 2024 07:00:00 GMT
Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer - PR Newswire
Tue, 12 Nov 2024 08:00:00 GMT
Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results - PR Newswire
Mon, 09 Dec 2024 08:00:00 GMT
Nuvalent Appoints Grant Bogle to Board of Directors - PR Newswire
Mon, 08 Jan 2024 08:00:00 GMT
Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated Milestones - PR Newswire
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.